Why is "Dexcom" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-04-13 23:30:18
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
Dexcom entered the ranking for the first time today at position #. This is its highest position ever recorded.
Trend History
This topic has appeared in the English Wikipedia rankings 1 time. It first appeared on 2026-04-13 and was most recently seen on 2026-04-13.
Wikipedia Overview
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A., and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Dexcom CFO to expand into COO role - Drug Delivery Business
-
Dexcom CFO to expand into COO role - MassDevice
-
DexCom Inc. stock outperforms competitors on strong trading day - MarketWatch
-
Dexcom (NASDAQ: DXCM) director plans $549,537.56 stock sale - Stock Titan
-
Here's Why You Should Retain DexCom Stock in Your Portfolio for Now - Yahoo Finance
-
Dexcom CFO Jereme Sylvain Takes on Chief Operations Role - Medical Product Outsourcing
-
Dexcom Promotes Jereme Sylvain to Chief Operating Officer - Business Wire
-
DexCom (DXCM) Appoints Former Medtech Finance Chief Glenn Boehnlein To Board - simplywall.st
-
Dexcom promotes Jereme Sylvain to EVP, COO and CFO - TradingView
-
Dexcom Announced as First Participant Selected for FDA's TEMPO Digital Health Devices Pilot Program - DexCom, Inc. - Investor Relations
-
Dexcom, Abbott await Medicare coverage expansion for CGMs - MedTech Dive
-
Dexcom Inc. stock gains as market cap approaches USD 32 billion - ad-hoc-news.de
-
FDA names Dexcom as first participant in digital health pilot - Healthcare Dive
-
Dexcom Appoints Glenn Boehnlein to Board of Directors - Yahoo Finance
-
Dexcom adds former Stryker CFO to board - Drug Delivery Business
-
Dexcom (NASDAQ: DXCM) director to sell 1,550 shares under Rule 144 - Stock Titan
-
Dexcom Reaffirms CGM Benefits for All People With Diabetes and Continues Momentum Toward Earlier Stage Intervention and Preventative Care at ADA 2026 - DexCom, Inc. - Investor Relations
-
DexCom (DXCM) Heads To A Healthcare Conference, Is The Stock Still A Bargain? - simplywall.st
-
DexCom Stock: Is DXCM Underperforming the Healthcare Sector? - Yahoo Finance
-
Scrapped CGM sensors stolen, sold to patients—Dexcom pledges to hold thieves accountable - Cardiovascular Business
-
DexCom appoints Glenn S. Boehnlein to Board and committees - TradingView
-
Dexcom, Inc. Announces Appointment of Jereme Sylvain as Executive Vice President and Chief Operating Officer, Effective September 14, 2026 - marketscreener.com
-
Signos grows foothold in weight loss wave fueled by GLP-1s with its AI health data tracking - CNBC
-
Here's How Much a $1000 Investment in DexCom Made 10 Years Ago Would Be Worth Today - Yahoo Finance
-
ADA: Dexcom CGM shows benefit in non-insulin diabetes patients - Fierce Biotech
-
Dexcom CGM Improves Glycemic Control in Non-Insulin-Treated Persons With T2D - Patient Care Online
-
Q2 Earnings Highs And Lows: DexCom (NASDAQ:DXCM) Vs The Rest Of The Patient Monitoring Stocks - Yahoo Finance
-
DexCom (DXCM) Stock Looks Undervalued On Fair Value While Earnings Look Fair - Yahoo Finance
-
FDA selects Dexcom for new digital health device pilot - Drug Delivery Business
-
Weekly Recap: CONNECT trial, 10%+ rev and Glenn S. Boehnlein joins board - TradingView
-
Dexcom unveils next-generation G8 CGM for real-time glucose monitoring - MobiHealthNews
-
Dexcom Announces Upcoming Conference Presentation - Business Wire
-
Dexcom (NASDAQ: DXCM) director gets 5,841-unit stock grant vesting over 3 years - Stock Titan
-
Dexcom at Wells Fargo conference: coverage push drives growth plan - Investing.com
-
Dexcom bolsters evidence for glucose sensors for Type 2 diabetes - MedTech Dive
-
DexCom Stock Up on Q2 Earnings & Revenue Beat, Margins Rise - Yahoo Finance
-
Abbott vs. DexCom: Which CGM Stock Is the Better Buy Now? - Yahoo Finance
-
DexCom (DXCM) Stock Sees Fair Value Lift After Analyst Target Increases - Yahoo Finance
-
Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes - Yahoo Finance
-
Dexcom CEO Jake Leach talks Nutrisense acquisition, type 2 push, next-gen G8 - Drug Delivery Business
-
Dexcom Report Addresses Recent Friction, Reliability Challenges - Medical Device and Diagnostic industry
-
Dexcom raises annual revenue forecast on strong demand for glucose monitors - Reuters
-
DAV, Dexcom unite to empower veterans living with diabetes - DAV : Disabled American Veterans
-
DexCom, Inc. Announces Appointment of Glenn S. Boehnlein as Director, Member of Operations & Innovation Committee and Audit Committee, Effective September 10, 2026 - marketscreener.com
-
Dexcom's glucose monitor use shows benefit in non-insulin diabetic patients in study - Reuters
-
FDA clears Dexcom’s Stelo OTC glucose monitor for use with children - Fierce Biotech
-
Dexcom discovers two lots of stolen G7 sensors being sold to the public - MobiHealthNews
-
Dexcom alerts users after faulty G7 glucose sensors stolen and resold - PennLive.com
-
Dexcom warns patients as stolen glucose sensors hit the market - Reuters
-
Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026 - DexCom, Inc. - Investor Relations
-
Dexcom to acquire wellness tracking company Nutrisense, launch enhanced Stelo app - Drug Delivery Business
-
Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes - Business Wire
-
Abbott vs. DexCom: Which CGM Stock Is the Better Option Right Now? - Yahoo Finance
-
Why Is DexCom (DXCM) Stock Rocketing Higher Today - Yahoo Finance
-
FDA taps Dexcom as first participant in digital health pilot - MobiHealthNews
-
Did DexCom, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - Morningstar
-
The FDA Has Issued a Warning on 2 Popular Glucose Monitors. You Won't Believe Why. - menshealth.com
-
Kakao Healthcare offers free Dexcom G7 receivers to CSAT takers with type 1 diabetes - Korea Biomedical Review
-
Truist raises DexCom stock price target to $87 on growth outlook - Investing.com
-
Dexcom’s latest executive pay disclosure covers new CEO’s big year - Medical Design & Outsourcing
-
Dexcom says third party stole, sold scrapped G7 CGM lots - Drug Delivery Business
-
Dexcom Reveals Details of G8 Continuous Glucose Monitoring Device - Medical Device and Diagnostic industry
-
Dexcom Finally Acknowledges Problems with the Dexcom G7 CGM - Medical Device and Diagnostic industry
-
Dexcom warns of scrapped glucose sensors being resold - MedTech Dive
-
Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin - Business Wire
-
Dexcom launches Flex CGM for type 2 diabetes in Germany - Drug Delivery Business
-
Dexcom unveils next-gen G8 CGM system, CEO Jake Leach explains new tech - Drug Delivery Business
-
Is Wall Street Bullish or Bearish on DexCom Stock? - Yahoo Finance
-
DexCom Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
-
MyLife integrates MyLoop automated insulin pump with Dexcom G7 - Drug Delivery Business
-
Dexcom raises annual revenue forecast on strong demand for glucose monitors - Yahoo Finance
-
Dexcom Q2 results beat expectations, lead to increased sales outlook - Drug Delivery Business
-
Here's How Much You'd Have If You Invested $1000 in DexCom a Decade Ago - Yahoo Finance
-
Dexcom promotes CFO Jereme Sylvain to dual COO role By Investing.com - Investing.com India
-
Investors’ Confidence in DexCom (DXCM) Rises as Growth Outlook Reassured - Yahoo Finance
-
Dexcom Schedules Second Quarter 2026 Earnings Release and Conference Call for July 30, 2026 at 4:30 p.m. Eastern Time - Yahoo Finance
-
DexCom (DXCM) Stock May Trade At A 37% Discount On Cash Flow - Yahoo Finance
-
Dexcom tweaks full-year outlook after reporting 13% growth in Q2 - Medical Device Network
-
Revisiting Stock Picks Dexcom, Bristol Myers Squibb, Quanta Services - Barron's
-
Dexcom launches enhanced Stelo app - Drug Delivery Business
-
Dexcom seeks expanded Medicare coverage of CGMs for Type 2 diabetes - MedTech Dive
-
In a first, Dexcom’s OTC glucose sensor is cleared for kids - MedTech Dive
-
Dexcom study highlights benefits of G7 CGM in non-insulin type 2 diabetes - Drug Delivery Business
-
Piper Sandler Raises its Price Target on DexCom (DXCM) - Yahoo Finance
-
Dexcom Reports Second Quarter 2026 Financial Results - Business Wire
-
Health Canada authorises Dexcom G7 15 Day CGM - Medical Device Network
-
Weekly Rundown: FDA names Dexcom as first TEMPO participant; Ardent Health tops 1M patient visits with ambient AI - Fierce Healthcare
-
How The DexCom (DXCM) Investment Story Is Shifting With New Guidance And Valuation Resets - Yahoo Finance
-
Dexcom RCT suggests CGM benefits for broad diabetes population - STAT
-
Patient Monitoring Stocks Q1 Results: Benchmarking DexCom (NASDAQ:DXCM) - Yahoo Finance
-
Stelo Adds Enhanced Smart Meal Logging Features as Dexcom Continues to Transform Personal Glucose Management - DexCom, Inc. - Investor Relations
-
Did FDA-App Recalls and Activist Pressure Just Rewire Dexcom’s (DXCM) Software-Driven Investment Narrative? - Yahoo Finance
-
Dexcom buys Nutrisense; Insulet rolls out patch pump update - MedTech Dive
-
Assessing DexCom (DXCM) Valuation After Recent Share Price Momentum - Yahoo Finance
-
Dexcom reaffirms full-year forecast after topping quarterly estimates - Yahoo Finance
-
Dexcom Uncovers Theft of Scrapped Product, Notifies Potentially Impacted Users - Business Wire
-
Here's Why You Should Add DexCom Stock to Your Portfolio Now - Yahoo Finance
-
DexCom Flex Launch Targets Wider Type 2 Market With Valuation Upside - Yahoo Finance
-
Dexcom's glucose monitor use shows benefit in non-insulin diabetic patients in study - KSL.com
-
DexCom’s Quarterly Earnings Preview: What You Need to Know - Yahoo Finance
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.